Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
28
Bearish filings
2
Named actors
18
Disclosed $ (bull / bear)
$482.7M + 2 of unknown size / size unknown
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-09-10 | Activist (13D) — reduced stake ORBIMED ADVISORS LLC | reduced its stake (13D/G amendment) | — | SEC ↗ |
| 2026-08-18 | Activist (13D) ORBIMED ADVISORS LLC | disclosed an activist stake (13D) | — | SEC ↗ |
| 2026-08-14 | Activist (13D) AH Bio Fund IV, L.P. | disclosed an activist stake (13D) | — | SEC ↗ |
| 2026-08-07 | Director ORBIMED ADVISORS LLC | bought | $30.0M | SEC ↗ |
| 2026-08-07 | Director ORBIMED ADVISORS LLC | bought | $4.9M | SEC ↗ |
5 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-08-07 | Director OrbiMed Genesis GP LLC | bought | $4.9M | SEC ↗ |
| 2026-08-07 | Director OrbiMed Capital GP IX LLC | bought | $30.0M | SEC ↗ |
| 2026-08-07 | Director OrbiMed Genesis GP LLC | bought | $30.0M | SEC ↗ |
| 2026-08-07 | Director OrbiMed Capital GP IX LLC | bought | $4.9M | SEC ↗ |
| 2026-08-07 | Director Chimovits Erez | bought | $4.9M | SEC ↗ |
| 2026-08-07 | Director Chimovits Erez | bought | $30.0M | SEC ↗ |
| 2026-08-07 | 10% owner / other Forbion Ventures Fund VII Cooperatief U.A. | bought | $30.2M | SEC ↗ |
| 2026-08-07 | 10% owner / other Forbion Ventures VII Management B.V. | bought | $30.2M | SEC ↗ |
| 2026-08-07 | 10% owner / other Forbion Ventures Fund VII Cooperatief U.A. | bought | $34.6M | SEC ↗ |
| 2026-08-07 | 10% owner / other Forbion Growth III Management B.V. | bought | $30.2M | SEC ↗ |
| 2026-08-07 | 10% owner / other Forbion Growth Opportunities Fund III Cooperatief U.A. | bought | $30.2M | SEC ↗ |
| 2026-08-07 | 10% owner / other Forbion Growth III Management B.V. | bought | $34.6M | SEC ↗ |
| 2026-08-07 | 10% owner / other Forbion Growth Opportunities Fund III Cooperatief U.A. | bought | $34.6M | SEC ↗ |
| 2026-08-07 | 10% owner / other Forbion Ventures VII Management B.V. | bought | $34.6M | SEC ↗ |
| 2026-08-07 | 10% owner / other AH Bio Fund IV, L.P. | bought | $19.8M | SEC ↗ |
| 2026-08-07 | 10% owner / other AH Equity Partners Bio IV, L.L.C. | bought | $19.8M | SEC ↗ |
| 2026-08-07 | 10% owner / other HOROWITZ BENJAMIN A | bought | $19.8M | SEC ↗ |
| 2026-08-07 | 10% owner / other Andreessen Marc L | bought | $19.8M | SEC ↗ |
| 2026-08-07 | Director Lubner David Charles | bought | $1.0M | SEC ↗ |
| 2026-08-07 | CEO and President Murdoch Travis | bought | $1.5M | SEC ↗ |